Payment overview · 2025
General Payments
$245.02
13 reported records · 6 companies
Healthcare provider profile · identity verified
Alison Wright, MD
Allopathic & Osteopathic Physicians|Family Medicine · LAFAYETTE, IN · NPI 1043305279
Verified facts
What the public records show
CMS Open Payments records show Alison Wright, MD received $245.02 in general payments during 2025 across 13 reported records.
Abbott Laboratories accounted for 40.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 184 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $99.45 | 40.6% | 5 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $36.84 | 15.0% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $36.20 | 14.8% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $35.07 | 14.3% | 2 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$21.44 | 8.8% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $16.02 | 6.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $245.02 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $99.45 | 5 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $36.84 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $36.20 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $35.07 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $35.07 | 2 | 2025 |
Source payment records
|
|||||
| INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim |
Device | Medtronic, Inc. | $21.44 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $16.02 | 1 | 2025 |
Source payment records
|
|||||
| ENFLONSIA Normalized: enflonsia |
Drug | Merck Sharp & Dohme LLC | $16.02 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $16.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 184 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
184 | 36 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1240 | 412 |
| Levothyroxine Sodium | Levothyroxine Sodium | 894 | 280 |
| Amlodipine Besylate | Amlodipine Besylate | 783 | 242 |
| Lisinopril | Lisinopril | 679 | 218 |
| Losartan Potassium | Losartan Potassium | 434 | 145 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 417 | 132 |
| Metformin Hcl | Metformin Hcl | 399 | 138 |
| Metoprolol Succinate | Metoprolol Succinate | 390 | 125 |
| Omeprazole | Omeprazole | 381 | 129 |
| Gabapentin | Gabapentin | 377 | 97 |
| Simvastatin | Simvastatin | 314 | 93 |
| Glimepiride | Glimepiride | 293 | 95 |
| Pantoprazole Sodium | Pantoprazole Sodium | 269 | 83 |
| Furosemide | Furosemide | 263 | 80 |
| Tamsulosin Hcl | Tamsulosin Hcl | 259 | 97 |
| Hydrochlorothiazide | Hydrochlorothiazide | 247 | 76 |
| Eliquis | Apixaban | 227 | 47 |
| Alprazolam | Alprazolam | 213 | 53 |
| Meloxicam | Meloxicam | 192 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 190 | 69 |
| Ozempic | Semaglutide | 184 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 179 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 175 | 59 |
| Montelukast Sodium | Montelukast Sodium | 171 | 58 |
| Fluoxetine Hcl | Fluoxetine Hcl | 148 | 45 |
| Trazodone Hcl | Trazodone Hcl | 148 | 48 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 145 | 45 |
| Allopurinol | Allopurinol | 140 | 44 |
| Sertraline Hcl | Sertraline Hcl | 134 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 129 | 39 |
| Potassium Chloride | Potassium Chloride | 127 | 41 |
| Alendronate Sodium | Alendronate Sodium | 126 | 48 |
| Metformin Hcl Er | Metformin Hcl | 120 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 115 | 50 |
| Spironolactone | Spironolactone | 109 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 107 | 34 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 107 | 97 |
| Tramadol Hcl | Tramadol Hcl | 104 | 32 |
| Ezetimibe | Ezetimibe | 99 | 34 |
| Atenolol | Atenolol | 91 | 26 |
| Carvedilol | Carvedilol | 91 | 32 |
| Fenofibrate | Fenofibrate,micronized | 91 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 88 | 20 |
| Pregabalin | Pregabalin | 86 | 14 |
| Donepezil Hcl | Donepezil Hcl | 84 | 37 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 83 | 27 |
| Oxybutynin Chloride | Oxybutynin Chloride | 79 | 23 |
| Azithromycin | Azithromycin | 78 | 62 |
| Bupropion Xl | Bupropion Hcl | 78 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 78 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 74 | 21 |
| Buspirone Hcl | Buspirone Hcl | 73 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 73 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 21 |
| Xarelto | Rivaroxaban | 71 | 22 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 70 | 56 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 70 | 16 |
| Jardiance | Empagliflozin | 70 | 20 |
| Januvia | Sitagliptin Phosphate | 69 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 26 |
| Trulicity | Dulaglutide | 67 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 66 | 23 |
| Synthroid | Levothyroxine Sodium | 66 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 28 |
| Methylprednisolone | Methylprednisolone | 61 | 54 |
| Famotidine | Famotidine | 60 | 22 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 58 | 58 |
| Mirtazapine | Mirtazapine | 58 | 18 |
| Finasteride | Finasteride | 55 | 19 |
| Cephalexin | Cephalexin | 51 | 31 |
| Estradiol | Estradiol | 51 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 16 |
| Irbesartan | Irbesartan | 48 | 14 |
| Prednisone | Prednisone | 48 | 13 |
| Clonazepam | Clonazepam | 47 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 47 | 17 |
| Fluconazole | Fluconazole | 46 | 27 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 41 | 14 |
| Benazepril Hcl | Benazepril Hcl | 40 | 13 |
| Propranolol Hcl | Propranolol Hcl | 40 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Baclofen | Baclofen | 38 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 38 | 12 |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | 13 |
| Fenofibrate | Fenofibrate | 37 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | 11 |
| Celecoxib | Celecoxib | 34 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 31 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Acyclovir | Acyclovir | 30 | 14 |
| Temazepam | Temazepam | 30 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 30 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 30 | 11 |
| Mounjaro | Tirzepatide | 29 | suppressed |
| Invokana | Canagliflozin | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 17 |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | 11 |
| Torsemide | Torsemide | 25 | 13 |
| Warfarin Sodium | Warfarin Sodium | 25 | 11 |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 11 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 17 |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Indapamide | Indapamide | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 12 |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Sucralfate | Sucralfate | 18 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Lorazepam | Lorazepam | 16 | suppressed |
| Nabumetone | Nabumetone | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $245.02 · 13 records | Abbott Laboratories | CAPVAXIVE, Cologuard Collection Kit, Dexcom G6 Transmitter, ENFLONSIA, FREESTYLE LIBRE 3, GARDASIL 9, INTELLIS ADAPTIVESTIM, Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error